Pediatric Adhesion and New Dermal Approach Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

36 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-08-15

Study Completion Date

2025-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to see if the Zio® monitor device can be worn by children for up to 14-days and to determine if the skin preparation process will provide good adherence to the skin and clear signal quality. The Zio® monitor (Study Device) is an adhesive patch that is worn on the upper left chest for a specified period of time and is similar to a band aid. The Study Device contains a battery-powered heart monitor and will look at the heart rhythm and rate.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Evaluation of a Test Algorithm for Use to Analyze ECG Data Collected From a Test Device of a 24-hour Simulated Use Period

NCT07188129

Atrial Fibrillation (AF) Tachycardia Bradycardia +2 more

COMPLETED NA

True Continuous ECG Monitoring (TCEM Study)

NCT01559246

Cardiac Arrhythmia

COMPLETED

A Three-phase Study That Will Compare the ECG Data Recorded Using the Test Device With the Data Recorded by a Reference Device, Evaluate the ECG Signal Quality of the Test Device Over a 10-day Simulated Use Period, and Assess the Effects of Variable ECG Electrode Placement for the Test Device

NCT07200232

Healthy Subjects

COMPLETED NA

Imaging Study of Lead Implant for His Bundle Pacing

NCT03294317

Cardiac Pacemaker, Artificial

COMPLETED

Validation Study: Extended Wear Performance of the Zio Monitor - SHASTA II

NCT07205367

Cardiac Arrhythmia

ACTIVE_NOT_RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a prospective single-arm study to demonstrate adequate analyzable time for use in pediatric patients up to 14 days of device wear. The study will incorporate a simplified skin preparation procedure. The objective is to evaluate analyzable time of the Zio® monitor device over the wear duration (up to 14 days) in a population 1 to 17 years of age. The study will incorporate a simplified skin preparation procedure.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Syncope Pediatric Congenital Athymia Congenital Heart Disease Arrhythmia Arrhythmia in Children

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Single-arm study to analyzable time for use in pediatric patients up to 14 days

Zio monitor

Group Type OTHER

Zio monitor

Intervention Type DEVICE

Evaluate analyzable time of the Zio monitor over the wear duration of up to 14 days in a pediatric population.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Zio monitor

Evaluate analyzable time of the Zio monitor over the wear duration of up to 14 days in a pediatric population.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Child is \<18 years of age and ≥1 year of age and weighing \>10 kg (22 pounds) at the time of device application.
2. Child's legally authorized representative is willing and able to provide informed consent and be able to assist the Child in completing all visits for the study. If the Child is old enough to provide assent, it will also be captured.
3. The prescribed Zio monitor wear time is planned to be up to 14 days.

Exclusion Criteria

1. Child has a known allergy to adhesives or hydrogels or with family history of adhesive skin allergies.
2. Child has a visible skin injury or broken skin at location for study device placement.
3. Child has skin damage and a discharge of clear fluid or pus at the location for study device placement.
4. Child is unable or unwilling to participate or comply with study protocol.
5. The local Investigator deems the Child has a condition that could limit the Child's ability or willingness to participate in the study, or ability to comply with study required procedures and/or follow-up visits. (It is understood that younger age groups of children may present development behavioral challenges in compliance with use of medical devices. Normal development stage should not be considered a reason for exclusion).
6. The child has experienced symptomatic episodes where instance variations in cardiac performance could result in immediate danger to the child or when real-time or in-patient monitoring should be prescribed.
7. Child has an external or wearable cardiac defibrillator or may be exposed to high frequency surgical equipment near strong magnetic fields or devices such as MRI during the wear period.
8. Child has a neuro-stimulator, as it may disrupt the quality of ECG data.

Minimum Eligible Age

1 Year

Maximum Eligible Age

17 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No